ClinicalTrials.Veeva

Menu
CHEAR Center LLC | New York, NY logo

CHEAR Center LLC | New York, NY

Research site
About
Dr. Bernard Chief Medical Officer: CHEAR Center LLC is a multi-specialty medical clinical trial and research site located at 384 East 149th Street, Suite 205, 2nd Floor, Bronx NY 10455. Phone: 347 270 1111 and 718 600 1679. We conduct research studies on a variety of medical areas and illnesses for all ages. We work with a variety of pharmaceutical companies to develop new treatments and we focus on the participant’s research which may help to improve their overall health.

Site insights

Top conditions

Top treatments

Vericiguat
Plozasiran
Relamorelin
MK-1242
Ziltivekimab
Rocatinlimab
BLU-5937
MK-1242-035
Gemcabene
Olodaterol

Data sourced from clinicaltrials.gov

Contact this site

Jose Garcia, Coordinator

Verified by this site

Active trials

8 of 21 total trials
Locations recently updated

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES)

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...

Enrolling
Heart Failure
Drug: Placebo
Drug: Ziltivekimab

The purpose of this study is to evaluate the efficacy and safety of vericiguat in participants with chronic heart failure with reduced ejection fract...

Active, not recruiting
Chronic Heart Failure With Reduced Ejection Fraction
Drug: Vericiguat
Drug: Placebo

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Enrolling
Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo

This is a parallel group, Phase 3, multinational, multicenter, randomized, double blind, placebo-controlled, 3-arm monotherapy study for treatment of...

Enrolling
Dermatitis Atopic
Drug: Amlitelimab
Drug: Placebo

Researchers are looking for a better way to treat people who have chronic heart failure with reduced ejection fraction. Chronic heart failure with re...

Active, not recruiting
Chronic Heart Failure With Reduced Ejection Fraction
Drug: Vericiguat (BAY1021189) 5 mg

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia (HTG). A...

Enrolling
Hypertriglyceridemia
Drug: Placebo
Drug: Plozasiran Injection

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (...

Enrolling
Severe Hypertriglyceridemia
Drug: Plozasiran Injection
Drug: Placebo

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Active, not recruiting
Lower Respiratory Tract Illness
Biological: RSVpreF
Biological: Placebo

Trial sponsors

Allergan logo
Arrowhead Pharmaceuticals logo
Boehringer Ingelheim logo
A
Amgen logo
Bavarian Nordic logo
Bayer logo
B
Gilead Sciences logo
Janssen (J&J Innovative Medicine) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems